公司News-2025-01-31
早上好，今日有 14 条新闻更新。
Colgate-Palmolive Reports Record 2024 Financial Results\n公司：CL\n\nColgate-Palmolive Company announced its financial results for the fourth quarter and full year of 2024, achieving over $20 billion in net sales for the first time. The company reported a 3.3% increase in net sales and a 7.4% rise in organic sales for the year. The GAAP earnings per share (EPS) increased by 27% to $3.51, while the Base Business EPS rose by 11% to $3.60. Net cash provided by operations was $4.107 billion, marking a 10% increase from 2023. Colgate returned $3.4 billion to shareholders through dividends and share repurchases.\n\nIn the fourth quarter, net sales slightly decreased by 0.1%, but organic sales grew by 4.3%. The GAAP EPS for the quarter increased by 3% to $0.90, and the Base Business EPS rose by 5% to $0.91. The gross profit margin improved by 70 basis points to 60.3%.\n\nLooking ahead to 2025, Colgate expects net sales to remain roughly flat, with a mid-single-digit negative impact from foreign exchange. The company anticipates organic sales growth within its long-term target range of 3% to 5% and mid-single-digit earnings-per-share growth on a GAAP basis. The company plans to continue investing in advertising and innovation to drive future growth.
原文: colgate-announces-4th-quarter-and-full-year-2024-results-2025-01-31.pdf
Imperial Oil Declares Increased Dividend for Q1 2025\n公司：IMO\n\nImperial Oil Limited (TSE: IMO, NYSE American: IMO) has announced a quarterly dividend of 72 cents per share for the first quarter of 2025. This marks an increase from the previous quarter's dividend of 60 cents per share. The dividend will be payable on April 1, 2025, to shareholders recorded by the close of business on March 5, 2025. \n\nImperial Oil has a longstanding history of financial stability and growth within Canada's petroleum industry, having paid dividends annually for over a century. Notably, the company has increased its annual dividend payment for 30 consecutive years. As a leader in the industry, Imperial continues to focus on technology and innovation to responsibly develop Canada's energy resources. \n\nThe company is recognized as Canada's largest petroleum refiner, a significant crude oil producer, a key petrochemical producer, and a leading fuels marketer nationwide. Imperial remains committed to maintaining high standards across all business areas. \n\nFor further details, the full press release can be viewed on Business Wire.
原文: imperial-declares-first-quarter-2025-dividend-2025-01-31.pdf
Imperial Oil Declares Increased First Quarter 2025 Dividend\n公司：XOM\n\nImperial Oil Limited has announced a first quarter 2025 dividend of 72 cents per share, marking an increase from the fourth quarter 2024 dividend of 60 cents per share. This dividend will be payable on April 1, 2025, to shareholders recorded by March 5, 2025. This increase highlights Imperial's commitment to financial growth and stability, continuing its tradition of annual dividend increases for 30 consecutive years. As a leading entity in Canada's petroleum industry, Imperial Oil remains dedicated to leveraging technology and innovation to responsibly develop energy resources.
原文: imperial-declares-first-quarter-2025-dividend-2025-01-31.pdf
AbbVie Reports 2024 Financial Results: Revenue Growth Amid EPS Decline\n公司：ABBV\n\nAbbVie announced its financial results for 2024, highlighting a 3.7% increase in full-year net revenues to $56.334 billion. However, the company reported a 12.1% decrease in GAAP diluted EPS to $2.39 and an 8.9% decrease in adjusted diluted EPS to $10.12. These declines were influenced by a $1.52 per share impact from acquired IPR&D and milestones expenses.\n\nThe immunology portfolio generated $26.682 billion in global net revenues, marking a 2.1% increase. Notably, Skyrizi and Rinvoq saw significant growth, with revenues of $11.718 billion and $5.971 billion, respectively. The oncology portfolio also performed well, with a 10.8% increase in revenues to $6.555 billion.\n\nIn the fourth quarter, AbbVie reported a diluted loss per share of $0.02 on a GAAP basis, impacted by a partial intangible asset impairment charge. Adjusted diluted EPS was $2.16, with a 5.6% increase in net revenues to $15.102 billion.\n\nLooking ahead, AbbVie provided a 2025 adjusted diluted EPS guidance range of $12.12 to $12.32 and reaffirmed expectations for a high single-digit compound annual revenue growth rate through 2029. The company also raised its 2027 sales outlook for Skyrizi and Rinvoq to over $31 billion.
原文: abbvie-reports-full-year-and-fourth-quarter-2024-financial-results-2025-01-31.pdf
Church & Dwight Reports Strong 2024 Financial Results and Positive 2025 Outlook\n公司：CHD\n\nChurch & Dwight Co., Inc. reported a 4.1% increase in net sales for 2024, reaching $6,107.1 million, surpassing their projected growth of approximately 3.5%. Organic sales rose by 4.6%, driven by a 3.3% increase in volume and a 1.3% positive pricing and mix. The company's adjusted gross margin improved by 110 basis points. Reported EPS for the year was $2.37, a decrease of 22.3% due to non-cash asset impairment charges, while adjusted EPS increased by 8.5% to $3.44.\n\nIn the fourth quarter, net sales grew by 3.5% to $1,582.0 million, exceeding expectations. Organic sales increased by 4.2%, with reported EPS at $0.76 and adjusted EPS at $0.77, marking an 18.5% increase from Q4 2023.\n\nFor 2025, Church & Dwight anticipates reported sales growth of 2.5% to 3.5% and organic sales growth of 3-4%. The company expects full-year reported EPS to rise by 53% to 55%, with adjusted EPS growth projected at 7% to 8%. Cash flow from operations is expected to remain strong at approximately $1.15 billion. The company also announced a 4% increase in its quarterly dividend, reflecting confidence in its financial performance and future prospects.
原文: church-dwight-reports-fourth-quarter-and-full-year-2024-results-2025-01-31.pdf
Grainger Reports Fourth Quarter and Full Year 2024 Results; Issues 2025 Guidance\n公司：GWW\n\nW.W. Grainger, Inc. announced its financial results for Q4 and the full year 2024, highlighting a 5.9% increase in Q4 sales to $4.2 billion and a 4.2% rise in full-year sales to $17.2 billion. The company achieved a Q4 operating margin of 15.0%, up 110 basis points, and a full-year operating margin of 15.4%, slightly down by 20 basis points. Diluted EPS for Q4 rose by 23.1% to $9.71, while the full-year EPS increased by 6.8% to $38.71.\n\nFor 2025, Grainger projects net sales between $17.6 billion and $18.1 billion, with a daily, constant currency sales growth of 4.0% to 6.5%. The company anticipates a gross profit margin of 39.1% to 39.4% and an operating margin of 15.1% to 15.5%. Diluted EPS is expected to range from $39.00 to $41.50.\n\nGrainger generated $2.1 billion in operating cash flow in 2024, returning $1.6 billion to shareholders through dividends and share repurchases. The company plans to continue its strategic focus on customer relationships and operational capabilities in 2025.
原文: grainger-reports-results-fourth-quarter-and-full-year-2024-2025-01-31.pdf
Phillips 66 Reports Fourth-Quarter Results and Strategic Initiatives\n公司：PSX\n\nPhillips 66 reported fourth-quarter earnings of $8 million or $0.01 per share, with an adjusted loss of $61 million or $0.15 per share. The earnings were significantly impacted by $230 million pre-tax of accelerated depreciation related to the Los Angeles Refinery. The company returned $1.1 billion to shareholders through dividends and share repurchases.\n\nFor the full year 2024, Phillips 66 reported earnings of $2.1 billion or $4.99 per share, with adjusted earnings of $2.6 billion or $6.15 per share. Operating cash flow was $4.2 billion, or $4.8 billion excluding working capital, and $5.3 billion was returned to shareholders.\n\nThe company achieved $1.5 billion in run-rate business transformation savings and $500 million in synergy capture from the successful DCP integration. Phillips 66 also surpassed its targeted $3 billion in announced asset dispositions.\n\nLooking forward, Phillips 66 has set new financial and operational targets through 2027, focusing on debt reduction, a lowered cost structure, and EBITDA growth. The company aims to return over 50% of operating cash flow to shareholders, reduce total debt to $17 billion, and grow Midstream and Chemicals mid-cycle adjusted EBITDA by $1 billion in total by 2027.
原文: phillips-66-reports-fourth-quarter-results-and-announces-next-phase-strategic.pdf
Aon Reports Strong Financial Results for Q4 and Full Year 2024\n公司：AON\n\nAon plc (NYSE: AON) announced its financial results for Q4 and the full year 2024, showcasing significant growth and strong performance. Total revenue for Q4 2024 increased by 23% to $4.147 billion, compared to $3.375 billion in the same period of 2023. For the full year, revenue rose by 17% to $15.698 billion from $13.376 billion in 2023. The company achieved an organic revenue growth of 6% for both the quarter and the year.\n\nNet income attributable to Aon shareholders for Q4 increased by 44% to $716 million, or $3.28 per diluted share, compared to $498 million, or $2.47 per diluted share, in Q4 2023. Adjusted net income per share rose by 14% to $4.42. For the full year, net income was $2.7 billion, or $12.49 per diluted share, with adjusted net income per share increasing by 10% to $15.60.\n\nOperating margin for Q4 improved to 26.3% from 23.1%, while the adjusted operating margin slightly decreased to 33.3% from 33.8%. Cash provided by operations for the year decreased by 12% to $3.035 billion, and free cash flow fell by 11% to $2.817 billion.\n\nLooking ahead, Aon introduced 2025 guidance, aiming for mid-single-digit or greater organic revenue growth, adjusted margin expansion, and double-digit free cash flow growth. The company plans to continue its capital allocation strategy, including $1 billion in share repurchases.
原文: aon-reports-fourth-quarter-and-full-year-2024-results-2025-01-31.pdf
PTC Therapeutics and Novartis Collaborate on PTC518 Huntington's Disease Program\n公司：NVS\n\nPTC Therapeutics, Inc. has entered into a global license and collaboration agreement with Novartis Pharmaceuticals for its PTC518 Huntington's disease program. Under this agreement, PTC will receive an upfront payment of $1.0 billion and is eligible for up to $1.9 billion in development, regulatory, and sales milestones. Additionally, PTC will share profits in the U.S. and receive tiered double-digit royalties on ex-U.S. net sales.\n\nNovartis will take over global development, manufacturing, and commercialization responsibilities after the completion of the placebo-controlled portion of the ongoing PIVOT-HD study, expected in the first half of 2025. The companies will share U.S. profits and losses on a 40/60 basis, with PTC receiving 40% and Novartis 60%.\n\nPTC518, discovered from PTC's splicing platform, is currently in Phase 2 trials and has shown promising results, including a reduction in mutant Huntingtin protein levels and early clinical benefits. The transaction is expected to close in the first quarter of 2025, subject to regulatory clearance and customary closing conditions.
原文: ptc-therapeutics-enters-global-license-and-collaboration-agreement-novartis-ptc518.pdf
LyondellBasell Reports 2024 Earnings with Strategic Focus on Growth\n公司：LYB\n\nLyondellBasell Industries (NYSE: LYB) announced its financial results for the fourth quarter and full year 2024, highlighting significant strategic progress despite challenging market conditions. The company generated $3.8 billion in cash from operating activities, with a 90% cash conversion rate. This cash flow funded $1.8 billion in capital expenditures and $1.9 billion in shareholder returns through dividends and share repurchases.\n\nFor the full year 2024, LyondellBasell reported a net income of $1.4 billion, or $4.15 per share, down from $2.1 billion in 2023. The company recognized identified items totaling $734 million, impacting earnings by $2.25 per share. Full-year EBITDA was $3.5 billion, or $4.3 billion excluding identified items.\n\nIn the fourth quarter, the company faced a net loss of $603 million, or $1.87 per share, due to identified items including asset write-downs and refinery exit costs. EBITDA for the quarter was $(409) million, or $689 million excluding identified items.\n\nLyondellBasell's Circular and Low Carbon Solutions business saw a 65% year-over-year volume growth. The company remains committed to its strategy of value-added growth, aiming to deliver $3 billion of incremental Normalized EBITDA by 2027. Looking ahead, LYB anticipates gradual market recovery and continues to align its operations with global demand.
原文: lyondellbasell-reports-2024-earnings-2025-01-31.pdf
Eaton Reports Record Fourth Quarter 2024 Results and 2025 Outlook\n公司：ETN\n\nEaton Corporation plc announced record financial results for the fourth quarter of 2024, with earnings per share (EPS) reaching $2.45, a 4% increase from 2023. Adjusted EPS was $2.83, marking an 11% rise. The company achieved record segment margins of 24.7%, up 190 basis points from the previous year. Sales for the quarter were $6.2 billion, a 5% increase, despite challenges like Hurricane Helene and aerospace industry strikes.\n\nFor the full year 2024, Eaton reported record EPS of $9.50 and adjusted EPS of $10.80, an 18% increase from 2023. The company also recorded sales of $24.9 billion, up 7% from the previous year, with organic sales growth of 8%.\n\nLooking ahead to 2025, Eaton projects EPS between $10.60 and $11.00, a 14% increase at the midpoint, and adjusted EPS between $11.80 and $12.20, up 11% at the midpoint. The company anticipates organic growth of 7-9% and segment margins of 24.4-24.8%.\n\nEaton's strong performance is attributed to robust demand and effective execution, with significant backlog growth in Electrical and Aerospace segments. The company remains optimistic about continued momentum into 2025, driven by global trends in electrification and digitalization.
原文: eaton-reports-record-fourth-quarter-2024-results-strong-orders-and-backlog-growth-and.pdf
Charter Communications Reports Q4 and Full Year 2024 Financial Results\n公司：CHTR\n\nCharter Communications, Inc. reported its financial results for Q4 and the full year 2024. The company saw a 1.6% increase in Q4 revenue, reaching $13.9 billion, driven by significant growth in residential mobile service revenue (37.4%) and advertising sales (26.4%). However, residential video revenue declined by 7.4%. Net income attributable to Charter shareholders for Q4 was $1.5 billion, a 38.6% increase from the previous year. For the full year, net income was $5.1 billion.\n\nAdjusted EBITDA for Q4 was $5.8 billion, up 3.4% year-over-year, while the full year Adjusted EBITDA was $22.6 billion, marking a 3.1% increase from 2023. Full-year revenue grew by 0.9% to $55.1 billion.\n\nCharter's capital expenditures for 2024 totaled $11.3 billion, with $4.2 billion allocated to line extensions. The company reported full-year net cash flows from operating activities of $14.4 billion, consistent with the previous year, and free cash flow increased to $4.3 billion from $3.5 billion in 2023.\n\nThe company also repurchased 4.3 million shares of its Class A common stock and Charter Holdings common units for approximately $1.3 billion. Charter's strategic investments in network evolution and expansion are expected to drive future growth in customer base and profitability.
原文: charter-announces-fourth-quarter-and-full-year-2024-results-2025-01-31.pdf
Broadridge Reports Strong Q2 Fiscal 2025 Results with Significant EPS Growth\n公司：BR\n\nBroadridge Financial Solutions, Inc. announced its second-quarter fiscal 2025 results, showcasing robust financial performance. Recurring revenues increased by 9% to $980 million, maintaining a constant currency growth rate of 9%. Total revenues rose by 13% to $1.589 billion. Operating income surged by 69% to $211 million, with an operating margin improvement to 13.3% from 8.9% in the previous year. Adjusted operating income also saw a significant rise of 51% to $263 million.\n\nNet earnings more than doubled, increasing by 103% to $142 million, while adjusted net earnings grew by 68% to $184 million. Diluted earnings per share (EPS) experienced a remarkable growth of 103% to $1.20, and adjusted EPS increased by 70% to $1.56.\n\nBroadridge reaffirmed its fiscal year 2025 guidance, projecting 6-8% recurring revenue growth in constant currency and 8-12% adjusted EPS growth. The company anticipates closed sales between $290 million and $330 million.\n\nCEO Tim Gokey highlighted the company's strong performance, driven by organic growth and strategic acquisitions, such as the acquisition of SIS. Broadridge continues to focus on its long-term strategy to innovate and modernize financial services, leveraging trends like increased investor participation.
原文: broadridge-reports-second-quarter-fiscal-2025-results-2025-01-31.pdf
Chevron Reports Fourth Quarter 2024 Results\n公司：CVX\n\nChevron Corporation announced its fourth-quarter 2024 financial results, reporting earnings of $3.2 billion or $1.84 per share (diluted), an increase from $2.3 billion or $1.22 per share in the same quarter of 2023. Adjusted earnings were $3.6 billion or $2.06 per share, down from $6.5 billion or $3.45 per share in the previous year. The company returned a record $27 billion to shareholders in 2024, including $15.2 billion in share repurchases and $11.8 billion in dividends.\n\nChevron's worldwide and U.S. production increased by 7% and 19%, respectively, reaching record levels. The company also announced a 5% increase in its quarterly dividend to $1.71 per share. \n\nFor the full year, Chevron's total earnings were $17.7 billion, down from $21.4 billion in 2023. The decrease was attributed to lower margins on refined product sales, lower realizations, and severance charges. Cash flow from operations was $31.5 billion, compared to $35.6 billion in 2023.\n\nChevron's capital expenditures for 2024 were $16.4 billion, slightly higher than the previous year, with affiliate capex decreasing by $1.1 billion. The company aims for $2-3 billion in structural cost reductions by the end of 2026.
原文: chevron-reports-fourth-quarter-2024-results-2025-01-31.pdf